G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2011
10/12/2011	CN101659954B Recombinant adenovirus expressing mycoplasma hyopneumoniae P102 protein and applications thereof
10/12/2011	CN101646938B Method and device for determining the phosphorus content of an aqueous sample
10/12/2011	CN101519448B Epididymal protease inhibitor protein monoclonal antibody and application thereof
10/12/2011	CN101490542B Method for assessing a state of a document of value with regard to limpness using ultrasound, and means for carrying out the method
10/12/2011	CN101201349B Sample analyzer, sample analyzing method and blood analysis device
10/12/2011	CN101042397B Reagent for analyzing urine and method for analyzing urine
10/11/2011	US8036868 Intergrated systems and methods of virtual or live microscope slide presentation
10/11/2011	US8036867 Method and apparatus for analysis of molecular configurations and combinations
10/11/2011	US8036833 Systems and methods for automated analysis of cells and tissues
10/11/2011	US8036832 Automatic threshold setting and baseline determination for real-time PCR
10/11/2011	US8036831 Ligand searching device, ligand searching method, program, and recording medium
10/11/2011	US8034928 Fluorescence assays with improved sensitivity
10/11/2011	US8034911 Nucleic acid anchoring system comprising covalent linkage of an oligonucleotide to a solid support
10/11/2011	US8034904 First therapeutic agent is an antibody or an epitope-binding fragment having the same amino acid sequence as the murine antibody EM164 produced by mouse hybridoma EM164; a second therapeutical agent selected from carboplatin, oxaliplatin, cisplatin, paclitaxel, docetaxel etc.; anticarcinogenic agents
10/11/2011	US8034636 Hydrophilic chemiluminescent acridinium labeling reagents
10/11/2011	US8034635 Methods of donor specific crossmatching
10/11/2011	US8034634 Ultra-sensitive magnetoreduction measurement system and ultra-sensitive, wash-free assay using the same
10/11/2011	US8034633 Microwave accelerated assays
10/11/2011	US8034632 Homogeneous immunoassays for multiple allergens
10/11/2011	US8034631 Systems for homogeneous immunoassays for multiple allergens
10/11/2011	US8034630 Protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same
10/11/2011	US8034624 Sampling device
10/11/2011	US8034623 Method for free radical initiated peptide sequencing
10/11/2011	US8034622 Selective detection of Hg2+ by calix[4]arenes
10/11/2011	US8034621 Chemical sensors of zinc, nickel, and copper ions
10/11/2011	US8034615 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same
10/11/2011	US8034609 patterning biomolecules on a substrate by coating the substrate with the biomolecules, applying a laser to the coating, and ablating a portion of the biomolecules with the laser in a predetermined pattern
10/11/2011	US8034578 PKP3 oncogene as a prognostic indicator for lung cancer
10/11/2011	US8034577 Methods and probes for detecting esophageal cancer
10/11/2011	US8034576 Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
10/11/2011	US8034575 Screening systems utilizing RTP801
10/11/2011	US8034574 Screening method for prokinetic agent
10/11/2011	US8034573 Identification of tissue for debridement
10/11/2011	US8034572 Using immobilized glial cell-line derived neurotrophic factor family ligand (GFL)/heparan sulfate proteoglycan (HSPG) complex as tool for identifying and screening modulators for prevention and treatment of neurodegenerative diseases
10/11/2011	US8034571 Microbial polynucleotides expressed during infection of a host
10/11/2011	US8034567 Amplification, calibration of sampling; diagnosis of tumors, cardiovascular disorders, central nervous system diosrders
10/11/2011	US8034558 Acridone derivatives as labels for fluorescence detection of target materials
10/11/2011	US8034556 Regulation of glucose and insulin levels by GnT-4 glycosyltransferase activity
10/11/2011	US8034553 Biomarkers for wound healing
10/11/2011	US8034551 Method, reagent and kit for malaria testing
10/11/2011	US8034550 Chemical screening system using strip arrays
10/11/2011	US8034549 Detection of cancer by elevated levels of BCL-2
10/11/2011	US8034548 Methods and materials for assessing prostate cancer therapies
10/11/2011	US8034397 Methods of making assay devices utilizing hollow particles
10/11/2011	US8034348 Prevention and treatment of amyloidogenic disease
10/11/2011	US8034346 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same
10/11/2011	US8034343 Methods of treating inflammatory disorders of the lungs
10/11/2011	US8034340 Method for treating an immune disorder by decreasing NIK-SIVA complex formation
10/11/2011	US8034339 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta
10/11/2011	US8034314 Photoreactive compound specifically binding to calcium binding proteins
10/11/2011	US8034305 Container segment assembly
10/11/2011	US8034302 Transparent conducting composites (TTCs) for creating chemically active surfaces
10/11/2011	US8034301 Test paper and porous membrane
10/11/2011	US8034296 Microfluidic card for RBC analysis
10/11/2011	US8034295 Ion analyzing apparatus and ion analyzing method
10/11/2011	US8034294 Medical monitoring/consumables tracking device
10/11/2011	US8034290 Reigniting flame in volatile organic compound device
10/11/2011	US8034259 Inorganic particle conjugates
10/11/2011	US8034223 Methods and apparatus for low resistance electrophoresis of prior-cast, hydratable separation media
10/11/2011	US8033162 Analyte sensors and methods of use
10/11/2011	CA2599537C Assist probes and method of using the same
10/11/2011	CA2590545C Method for coating membranes
10/11/2011	CA2589239C Stabilized inorganic nanoparticle, stabilized inorganic nanoparticle material, method for producing stabilized inorganic nanoparticle, and method for using stabilized inorganic nanoparticle
10/11/2011	CA2575519C Detection of truncation mutations by mass spectrometry
10/11/2011	CA2547788C Circularly polarized light method and device for determining wall thickness and orientations of fibrils of cellulosic fibres
10/11/2011	CA2516490C Measuring apparatus for determining an analyte in a liquid sample
10/11/2011	CA2507864C Methods of quantitation and identification of peptides and proteins
10/11/2011	CA2502272C Biosensor
10/11/2011	CA2488584C Methods, mixtures, kits and compositions pertaining to analyte determination
10/11/2011	CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor
10/11/2011	CA2465327C Nonhuman model animal of th2-mediated hyperimmune response
10/11/2011	CA2447663C Composition and use of substances for the stabilization of sulphur-containing amino acids
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/11/2011	CA2437043C Ligand detection method
10/11/2011	CA2432361C Methods and reagents for the rapid and efficient isolation of circulating cancer cells
10/11/2011	CA2424734C Nanoparticles comprising a metallic or semiconductor core which is covalently bound to a plurality of carbohydrate ligands
10/11/2011	CA2387780C Animal health diagnosis
10/11/2011	CA2373198C Cartridge for conducting a chemical reaction
10/11/2011	CA2157932C Production of human papillomavirus capsid protein and virus-like particles
10/06/2011	WO2011123844A2 Markers and assays for detection of neurotoxicity
10/06/2011	WO2011123837A2 Method and system using computer simulation for the quantitative analysis of glycan biosynthesis
10/06/2011	WO2011123788A1 Compositions and methods for the treatment of cancer
10/06/2011	WO2011123781A1 Detection of feline immunodeficiency virus
10/06/2011	WO2011123776A2 Method for detecting occult blood
10/06/2011	WO2011123677A2 Signal locking label free biosensing
10/06/2011	WO2011123655A1 Methods, systems and devices for separating tumor cells
10/06/2011	WO2011123615A1 Gene-based prediction of psa recurrence for clinically localized prostate cancer patients
10/06/2011	WO2011123601A2 Whole mouth malodor control by a combination of antibacterial and deodorizing agents
10/06/2011	WO2011123479A1 Quantitative measurement of nano / micro particle endocytosis with cell mass spectrometry
10/06/2011	WO2011123424A1 Screening methods for mitochondria katp modulators using cell lines
10/06/2011	WO2011123396A1 Compositions and methods for the removal of biofilms
10/06/2011	WO2011123388A1 Novel gene targets associated with amyotrophic lateral sclerosis and methods of use thereof
10/06/2011	WO2011123386A1 Methods for detecting raman scattering using aromatic compounds comprising phosphate and at least one non-laser light source
10/06/2011	WO2011123256A1 Apparatus for classifying documents using acoustic emission
10/06/2011	WO2011123166A2 Methods and systems for reducing dna fragmentation in a processed sperm sample
10/06/2011	WO2011123103A1 System and method for anti-cancer drug candidate evaluation
10/06/2011	WO2011123092A1 Optical detection system and/or method
10/06/2011	WO2011123070A1 A method of monitoring parasite development in blood
10/06/2011	WO2011123064A1 Assay
10/06/2011	WO2011123044A1 Method to detect tissue degradation leading to inflammation

1 ... 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 ... 3937